Novacyt S.A.
Company Profile
Novacyt is an international diagnostics business delivering a broad portfolio of in vitro and molecular diagnostic tests for a wide range of infectious diseases, enabling faster, more accurate, accessible testing to improve healthcare outcomes. The Company provides customers with a seamless sample-to-result workflow using its integrated and scalable instrumentation/solutions. The Company specialises in the design, manufacture, and supply of real-time PCR kits, reagents and a full range of laboratory and qPCR instrumentation for molecular biology research and clinical use. Novacyt offers one of the world's most varied and comprehensive range of qPCR assays, covering human, veterinary, biodefence, environmental, agriculture and food testing.
Investor Access
An investor webinar presentation by Lyn Rees, Chief Executive Officer, and Steve Gibson, Chief Financial Officer, relating to the FY 2025 results.
Investors can sign up to Investor Meet Company for free and register here: https://www.investormeetcompany.com/novacyt-sa/register-investor
| Event | Date |
| Year End | December |
| Half Year End | June |
| Preliminary Results* | May |
| Interim Results* | September |
| AGM* | August |
* Months based on previous announcements of this kind
